Global Antiemetics Drugs Market Size, Share, and COVID-19 Impact Analysis, Drug Type (Serotonin-Receptor Antagonists, Anticholinergics, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, and Others), By Application (Chemotherapy, Gastroenteritis, Post Operative Surgery, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Jun 2025
REPORT ID SI12003
PAGES 245
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Drug Type
      2. Market Attractiveness Analysis By Application
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising chemotherapy and cancer cases
    3. Restraints
      1.  Availability of alternative therapies
    4. Opportunities
      1.  Technological advancements in R&D
    5. Challenges
      1. Risk of drug resistance development
  6. Global Antiemetics Drugs Market Analysis and Projection, By Drug Type
    1. Segment Overview
    2. Serotonin-Receptor Antagonists
    3. Anticholinergics
    4. Dopamine Receptor Antagonists
    5. Neurokinin Receptor Antagonists
    6. Others
  7. Global Antiemetics Drugs Market Analysis and Projection, By Application
    1. Segment Overview
    2. Chemotherapy
    3. Gastroenteritis
    4. Post Operative Surgery
    5. Others
  8. Global Antiemetics Drugs Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Antiemetics Drugs Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Antiemetics Drugs Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. GSK plc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Cipla Limited 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Novartis AG 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Pfizer Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Viatris Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Merck & Co., Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Johnson & Johnson
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Astellas Pharma Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Baxter International Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Glenmark Pharmaceuticals Limited 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Teva Pharmaceutical Industries Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Eagle Pharmaceuticals, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Hikma Pharmaceuticals PLC 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Torrent Pharmaceuticals Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  2. Global Serotonin-Receptor Antagonists, Antiemetics Drugs Market, By Region, 2025-2035(USD Billion)
  3. Global Anticholinergics, Antiemetics Drugs Market, By Region, 2025-2035(USD Billion)
  4. Global Dopamine Receptor Antagonists, Antiemetics Drugs Market, By Region, 2025-2035(USD Billion)
  5. Global Neurokinin Receptor Antagonists, Antiemetics Drugs Market, By Region, 2025-2035(USD Billion)
  6. Global Others, Antiemetics Drugs Market, By Region, 2025-2035(USD Billion)
  7. Global Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  8. Global Chemotherapy, Antiemetics Drugs Market, By Region, 2025-2035(USD Billion)
  9. Global Gastroenteritis, Antiemetics Drugs Market, By Region, 2025-2035(USD Billion)
  10. Global Post Operative Surgery, Antiemetics Drugs Market, By Region, 2025-2035(USD Billion)
  11. Global Others, Antiemetics Drugs Market, By Region, 2025-2035(USD Billion)
  12. North America Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  13. North America Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  14. U.S.  Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  15. U.S.  Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  16. Canada Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  17. Canada Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  18. Mexico Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  19. Mexico Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  20. Europe Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  21. Europe Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  22. Germany Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  23. Germany Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  24. France Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  25. France Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  26. U.K.  Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  27. U.K.  Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  28. Italy Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  29. Italy Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  30. Spain Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  31. Spain Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  32. Asia Pacific Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  33. Asia Pacific Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  34. Japan Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  35. Japan Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  36. China Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  37. China Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  38. India Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  39. India Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  40. South America Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  41. South America Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  42. Brazil Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  43. Brazil Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  44. The Middle East and Africa Antiemetics Drugs Market, By Drug Type, 2025-2035(USD   Billion)
  45. The Middle East and Africa Antiemetics Drugs Market, By Application, 2025-2035(USD   Billion)
  46. UAE Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  47. UAE Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)
  48. South Africa Antiemetics Drugs Market, By Drug Type, 2025-2035(USD Billion)
  49. South Africa Antiemetics Drugs Market, By Application, 2025-2035(USD Billion)

 

List of Figures 

  1. Global Antiemetics Drugs Market Segmentation
  2. Antiemetics Drugs Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Antiemetics Drugs Market
  9. Top Winning Strategies, 2025-2035
  10. Top Winning Strategies, By Development, 2025-2035(%)
  11. Top Winning Strategies, By Company, 2025-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2025
  18. Market Share Analysis, 2025
  19. Restraint and Drivers:  Antiemetics Drugs Market
  20. Antiemetics Drugs Market Segmentation, By Drug Type
  21. Antiemetics Drugs Market For Serotonin-Receptor Antagonists, By Region, 2025-2035 ($ Billion)
  22.  Antiemetics Drugs Market For Anticholinergics, By Region, 2025-2035 ($ Billion)
  23. Antiemetics Drugs Market For Dopamine Receptor Antagonists, By Region, 2025-2035 ($ Billion)
  24. Antiemetics Drugs Market For Neurokinin Receptor Antagonists, By Region, 2025-2035 ($ Billion)
  25. Antiemetics Drugs Market For Others, By Region, 2025-2035 ($ Billion)
  26.  Antiemetics Drugs Market Segmentation, By Application
  27.  Antiemetics Drugs Market For Chemotherapy, By Region, 2025-2035 ($ Billion)
  28.  Antiemetics Drugs Market For Gastroenteritis, By Region, 2025-2035 ($ Billion)
  29. Antiemetics Drugs Market For Post Operative Surgery, By Region, 2025-2035 ($ Billion)
  30. Antiemetics Drugs Market For Others, By Region, 2025-2035 ($ Billion)
  31. GSK plc: Net Sales, 2025-2035 ($ Billion)
  32. GSK plc: Revenue Share, By Segment, 2025 (%)
  33. GSK plc: Revenue Share, By Region, 2025 (%)
  34. Cipla Limited: Net Sales, 2025-2035 ($ Billion)
  35. Cipla Limited: Revenue Share, By Segment, 2025 (%)
  36. Cipla Limited: Revenue Share, By Region, 2025 (%)
  37. Novartis AG: Net Sales, 2025-2035 ($ Billion)
  38. Novartis AG: Revenue Share, By Segment, 2025 (%)
  39. Novartis AG: Revenue Share, By Region, 2025 (%)
  40. Pfizer Inc.: Net Sales, 2025-2035 ($ Billion)
  41. Pfizer Inc.: Revenue Share, By Segment, 2025 (%)
  42. Pfizer Inc.: Revenue Share, By Region, 2025 (%)
  43. Viatris Inc.: Net Sales, 2025-2035 ($ Billion)
  44. Viatris Inc.: Revenue Share, By Segment, 2025 (%)
  45. Viatris Inc.: Revenue Share, By Region, 2025 (%)
  46. Merck & Co., Inc.: Net Sales, 2025-2035 ($ Billion)
  47. Merck & Co., Inc.: Revenue Share, By Segment, 2025 (%)
  48. Merck & Co., Inc.: Revenue Share, By Region, 2025 (%)
  49. Johnson & Johnson: Net Sales, 2025-2035 ($ Billion)
  50. Johnson & Johnson: Revenue Share, By Segment, 2025 (%)
  51. Johnson & Johnson: Revenue Share, By Region, 2025 (%)
  52. Astellas Pharma Inc.: Net Sales, 2025-2035 ($ Billion)
  53. Astellas Pharma Inc.: Revenue Share, By Segment, 2025 (%)
  54. Astellas Pharma Inc.: Revenue Share, By Region, 2025 (%)
  55. Baxter International Inc..: Net Sales, 2025-2035 ($ Billion)
  56. Baxter International Inc..: Revenue Share, By Segment, 2025 (%)
  57. Baxter International Inc..: Revenue Share, By Region, 2025 (%)
  58. Glenmark Pharmaceuticals Limited: Net Sales, 2025-2035 ($ Billion)
  59. Glenmark Pharmaceuticals Limited: Revenue Share, By Segment, 2025 (%)
  60. Glenmark Pharmaceuticals Limited: Revenue Share, By Region, 2025 (%)
  61. Teva Pharmaceutical Industries Limited: Net Sales, 2025-2035 ($ Billion)
  62. Teva Pharmaceutical Industries Limited: Revenue Share, By Segment, 2025 (%)
  63. Teva Pharmaceutical Industries Limited: Revenue Share, By Region, 2025 (%)
  64. Eagle Pharmaceuticals, Inc.: Net Sales, 2025-2035 ($ Billion)
  65. Eagle Pharmaceuticals, Inc.: Revenue Share, By Segment, 2025 (%)
  66. Eagle Pharmaceuticals, Inc.: Revenue Share, By Region, 2025 (%)
  67. Hikma Pharmaceuticals PLC: Net Sales, 2025-2035 ($ Billion)
  68. Hikma Pharmaceuticals PLC: Revenue Share, By Segment, 2025 (%)
  69. Hikma Pharmaceuticals PLC: Revenue Share, By Region, 2025 (%)
  70. Torrent Pharmaceuticals Limited: Net Sales, 2025-2035 ($ Billion)
  71. Torrent Pharmaceuticals Limited: Revenue Share, By Segment, 2025 (%)
  72. Torrent Pharmaceuticals Limited: Revenue Share, By Region, 2025 (%)
  73. Others: Net Sales, 2025-2035 ($ Billion)
  74. Others: Revenue Share, By Segment, 2025 (%)
  75. Others: Revenue Share, By Region, 2025 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:120
Pages:245
Countries covered:20
Companies covered::16
Forecast CAGR:CAGR of 5.70%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies